The Human Medicines Regulations 2012 No. 1916

SCHEDULES

SCHEDULE 24 U.K. Packaging information requirements

[F1 PART 4 U.K. Outer and immediate packaging: advanced therapy medicinal products for sale or supply in Great Britain only

Textual Amendments

F1 Sch. 24 Pts. 4, 5 inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 201(5) (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 155(d)); 2020 c. 1, Sch. 5 para. 1(1)

46.   The name and address of the holder of the UK marketing authorisation and, where applicable, the name of the representative appointed by the holder to represent him.]